Clinical trial
Investigating the Effectiveness of Message Intervention in Self-Management of Colon and Rectal Cancer Patients Receiving Oral Chemotherapy
NCT07851675 is registered in ClinicalTrials.gov with Ozlem as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigating the Effectiveness of Message Intervention in Self-Management of Colon and Rectal Cancer Patients Receiving Oral Chemotherapy
- Lead sponsor
- Ozlem
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 30, 2024
- Completion date
- August 30, 2026
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorektal cancer